top of page

2026 FASEB NAD Metabolism and Signaling SRC, Melbourne, Florida June 7–11, 2026

  • Writer: cambronne lab
    cambronne lab
  • Jul 2
  • 2 min read

Lulu returned from Florida where she again helped organize a successful meeting, serving in multiple roles including lead conference organizer, session chair, and presenter. The 2026 NAD⁺ Meeting is the latest in a biennial series that has grown since 2009, and remains the premier international conference focused on NAD biology.


The program was packed with science — two plenary talks from Lee Kraus (UT Southwestern) and Katrin Andreasson (Stanford Medicine), 51 oral presentations and 46 poster presentations, and 9 scientific sessions spanning the full NAD metabolome, from ADP-ribosylation and Sirtuins to NAD in aging, cancer, and neurobiology. The meeting also featured a Meet the Experts Luncheon, career development workshops, and clinical roundtables. 21 Invited Speakers (25 min + 5 min Q&A) anchored the 9 distinct scientific sessions that each included 2-3 invited talks with 3-5 short talks (12 min + 3 min Q&A) selected from abstracts. Session titles and sessions chairs are listed in Table 1.


Table 1.

Session

Title

Chair

1

NAD Metabolism and Physiological Roles

Clara Peek, Northwestern University

2

Biosynthesis and Compartmentalization

Joseph Baur, University of Pennsylvania

3

NAD Consumers CD38, SARM1/TIR-domain Enzymes

Aaron DiAntonio,

WUSTL

4

NAD Consumers Sirtuins and Poly and Mono-ADP Ribosylation

Giovanna Grimaldi, NRC Italy

5

NAD Signaling Biology

Santina Bruzzone, University of Genova

6

NAD-dependent Pathology I,

Mathias Ziegler, University of Bergen

7

NAD Redox and Pathology II

Melanie McReynolds, PennState

8

NAD in Humans and Human Aging

Eija Pirinen, University of Oulu

9

NAD in Neurobiology, AD and Other Dementias

Shin Imai, WUSTL

 

9 Sessions and Chairs:

4 out of 9 session chairs were female, 4 out of 9 session chairs were early-mid career, and 4 out of 9 session chairs were from non-USA academic institutions.

 

18 Additional Invited Speakers + 4 Meeting Organizers:

12 out of 21 were female, 9 out of 21 were early-mid career, 10 out of 21 were from non-USA institutions, and 9 out of 21 were new speakers to the meeting or had not participated in the last 5 years.



Conference Organizers:

Lulu Cambronne, Ph.D.

The University of Texas at Austin

 

Joseph Baur, Ph.D.

University of Pennsylvania

 

Giovanna Grimaldi, Ph.D.

National Research Council Italy

 

Shin-ichiro Imai, MD, Ph.D.

Washington University School of Medicine

 
 
 

Comments


bottom of page